$
18. 39
+0.05
+0.2781%
$
508.7M Market Cap
- P/E Ratio
- Div Yield
3,242 Volume
- Eps
$ 18.34
Previous Close Investors:
Want to track CBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crescent Biopharma, Inc. (CBIO) Statistics
Valuation metrics
Market Cap 508.7M
Enterprise value 308.67M
Trailing P/E (ttm) -3.38
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 41.77
Price/Book (mrq) 2.98
Enterprise Value/Revenue 25.98
Enterprise Value/EBITDA -1.94
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 192.4K
Average volume (90 days) 266.67K
Price summary
52-Week low 8.72
52-Week high 27.41
Beta -
50-Day moving average 20.7
200-Day moving average 14.46
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 12 Jan 2023
Ex-Dividend Date 13 Jan 2023
Last split factor 1:100
Last split Date 16 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -13.64%
Operating margin -13.73%
Operational effectiveness
Return on assets -0.81%
Return on equity -1.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.22
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 13.78%
Book value per share (mrq) 6.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
